{"id":"NCT00627367","sponsor":"Montefiore Medical Center","briefTitle":"Protocolized vs Nonprotocolized Treatment of Adult ED Patients With Acute Severe Pain","officialTitle":"A Randomized Controlled Trial Comparing Protocolized Versus Non-protocolized Treatment of Adult ED Patients With Acute Severe Pain","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2008-03","completion":"2008-03","firstPosted":"2008-03-03","resultsPosted":"2018-04-05","lastUpdate":"2018-04-05"},"enrollment":224,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Pain"],"interventions":[{"type":"DRUG","name":"Hydromorphone","otherNames":["Dilaudid"]},{"type":"DRUG","name":"Nonprotocolized","otherNames":["Usual Care"]}],"arms":[{"label":"Protocolized","type":"EXPERIMENTAL"},{"label":"Nonprotocolized","type":"ACTIVE_COMPARATOR"}],"summary":"Patients treated with protocolized pain management (1 mg of IV hydromorphone followed by an additional 1 mg IV hydromorphone if the patient wants more) will have better pain relief and no more adverse events than patients receiving non-protocolized pain management.","primaryOutcome":{"measure":"Patient Reported Change in Pain Intensity From Initial Administration of Analgesics (Baseline) to 60 Minutes Post-baseline.","timeFrame":"60 minutes","effectByArm":[{"arm":"Protocolized","deltaMin":5.5,"sd":2.9},{"arm":"Nonprotocolized","deltaMin":4.5,"sd":3}],"pValues":[]},"eligibility":{"minAge":"21 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":108},"commonTop":["Nausea","Pulse rate <60 beats/min","Pruritus","Oxygen saturation 90-94%","Systolic blood pressure <90 mmHg"]}}